Advanced Care. Personalized Treatment. Proven Results

Symphony’s Gene & Cell Therapy (GCT) program revolutionizes patient care through cutting-edge genetic and cellular innovations. While NCCN Guidelines exist for Cellular therapy, standardized Guidelines are unavailable for Gene therapy. Our expert medical team has written proprietary evidence-based Guidelines considering FDA approval information and Inclusion and exclusion criteria from clinical trials. We provide timely updates on FDA approvals and advancements, enabling clients to make informed decisions that enhance financial performance and healthcare strategies. Our commitment to knowledge and expertise ensures clients receive the highest quality care in this evolving field.

Our comprehensive management coordinates with manufacturers, specialty pharmacies, and treatment centers to ensure seamless delivery of therapies. Personalized case management by certified experts guarantees eligibility and appropriate treatment without delays. With integrated cost management, quality assurance, and risk mitigation, Symphony delivers tailored support for improved outcomes and enhanced value. Trust Symphony to guide you through the future of gene & cell therapy.

Learn More

Advanced Care. Personalized Treatment. Proven Results

Symphony’s Gene & Cell Therapy (GCT) program revolutionizes patient care through cutting-edge genetic and cellular innovations. We provide timely updates on FDA approvals and advancements, enabling clients to make informed decisions that enhance financial performance and healthcare strategies. Our commitment to knowledge and expertise ensures clients receive the highest quality care in this evolving field.

Our comprehensive management coordinates with manufacturers, specialty pharmacies, and treatment centers to ensure seamless delivery of therapies. Personalized case management by certified experts guarantees eligibility and appropriate treatment without delays. With integrated cost management, quality assurance, and risk mitigation, Symphony delivers tailored support for improved outcomes and enhanced value. Trust Symphony to guide you through the future of gene & cell therapy.

Learn More

The Symphony Gene & Cell Therapy Advantage

The Symphony Gene & Cell Therapy program is designed to revolutionize patient care through advanced genetic and cellular treatments. By staying ahead with the latest FDA approvals and industry developments, we provide comprehensive support and personalized case management. Our integrated approach ensures seamless coordination, cost-effective solutions, and optimized treatment outcomes. Here are three key features that set our program apart:

Innovative Knowledge and Insights

Our medical team has developed proprietary, evidence-based gene therapy guidelines using FDA approval data and clinical trial criteria. By staying updated on FDA approvals and advancements in gene and cellular therapies, we offer clients insights into the benefits and risks of these treatments. This enables our clients to make informed decisions that improve healthcare strategies and optimize financial performance in the evolving field of gene and cellular therapies.

Integrated End-to-End Management

We offer a holistic management approach that goes beyond traditional contracted rates. Our services include coordinating with manufacturers, specialty pharmacies, and treatment centers to ensure the seamless delivery and administration of therapies. Personalized case management by certified clinical experts ensures that patients receive appropriate and timely treatment.

Specialized Expertise and Quality Assurance

Our medical leadership team comprises top professionals in the field, ensuring the highest standards of care. We carefully select and partner with the best healthcare centers and providers, manage costs through customized contracts, and monitor treatment outcomes to deliver significant savings and optimal results for our clients.

Request Medical Review Sample

BEGIN YOUR JOURNEY TOWARDS ADVANCED GENE CELL THERAPY

Explore the Symphony Gene & Cell Therapy program's personalized, cutting-edge approach. Contact us today to discover how we can support you.

Get Started Now

Advanced Therapy Coordination

The Gene & Cell Therapy program offers a unique advantage as part of your health plan, ensuring you have access to the most advanced treatments available. Our team coordinates with leading manufacturers, specialty pharmacies, and treatment centers to deliver seamless and effective therapy, providing you with the best possible care.

Informed Decision-Making

We provide clear, detailed information about the latest gene and cellular therapies, including FDA approvals and clinical trial data. This empowers you to make informed decisions about your treatment options, understanding both the benefits and potential risks involved.

Extensive Expertise

Our Gene & Cell Therapy program is led by a team of top professionals with extensive experience in genetic and cellular treatments. We partner with premier healthcare centers and providers to deliver cutting-edge therapies, ensuring the highest standards of safety and efficacy. Our commitment to excellence ensures you receive the most effective care tailored to your specific needs.

Leading the Future of Gene Therapy Care

Our commitment is to provide you with personalized, up-to-date care and peace of mind.

Diagnoses & Treatments

The Symphony Benefits Solution provides extensive information on diagnoses eligible for gene or cellular therapy treatments.

The SYMPHONY team possesses comprehensive information on current treatment options and upcoming therapies tailored to specific diagnoses. Refer to the example provided below for details. For further information on advanced treatment options or inquiries related to gene and cellular therapies, please reach out to our dedicated Symphony Benefits Solution team for prompt assistance.

Request Medical Review Sample

Example of current treatment options & pipeline by diagnosis

  1. Hemophilia A – Hemophilia A is a genetic bleeding disorder where the blood does not clot properly. This is because the body is missing or has low levels of a protein called factor VIII, which is needed for blood clotting. People with Hemophilia A may bleed for a longer time after an injury, surgery, or even without an obvious cause.
    1. FDA-Approved Therapies
      1. Roctavian (BioMarin Pharmaceutical)
        1. In-vivo Gene Therapy
        2. Approved 06/2023
        3. One-time dosing
        4. WAC pricing – $90,625.00
        5. Locations – All treatment centers and Hospital Pharmacies have access to RoctavianTM thru Specialty Pharmacy (Accredo, Caremark CVS, Optum Frontier Therapies, & Orsini) & Specialty Distribution partners (The Alliance Pharmacy, AmerisourceBergen SD, BioCare Inc., & CuraScript) that are verified to store, mix, and administer Roctavian
    2. Clinical Trials in pipeline working toward FDA Approval
      1. giroctocogene fitelparvovec
        1. NCT04370054
        2. Phase III
        3. Clinical trial started 08/2020 with planned study completion 10/2028
        4. Locations
          1. California and Washington states & International